Dr. Sung-wuk Kim

Corporate Board Member

Dr. Sung-wuk Kim is an entrepreneur, angel investor and accomplished inventor who has made significant contributions to advance drug development: receiving more than 30 patents in a broad range of areas which include formulation, biologics and small molecule drugs.

He is currently Co-CEO of Nexyon, a lipid metabolism company established in 2020. He serves as the Chairman of the Board of Directors at ImmunoMet Therapeutics.

Dr. Kim was formerly CEO of HanAll Biopharma and served on its Board of Directors (2003 - 2020). He was Chair of the R&D Committee at Daewoong Pharma Group (2015 - 2020). Dr. Kim has also served on the Board of Directors of Humasis Inc, a diagnostics kit development company (2002 - 2015) and Hangen Biotech, a RSV vaccine development company (2002 - 2004). Prior to devoting his career to drug development, Dr. Kim founded an IT entrepreneurial company, Freechal Inc, first XML platform internet community service provider, in 1999. He served on its Board of Directors until 2002.

Dr. Kim earned his Doctorate of Dental Surgery from Yonsei University in Korea and currently resides in Seoul with his family.